Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 2,744 shares at $119.82 ($329K) on 2017-04-27, disclosed to the SEC on 2017-04-28.
Seasonal sale ($329k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.82 | 1,700 | $204K | 61.8% |
| 2 | $120.45 | 522 | $63K | 19.1% |
| 3 | $120.45 | 522 | $63K | 19.1% |
| Total | $120.06 avg | 2,744 | $329K | 100% |
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |